TXMD earnings call for the period ending September 30, 2019.
News & Analysis: TherapeuticsMD, Inc.
Investors are bracing for dilution from a proposed share offering.
The path ahead is looking a bit brighter for this pharmaceutical company.
August sales figures suggest the company's strategy is working.
The women’s health expert logged a solid second quarter.
Investors are cheering second-quarter results that were better than expected, and an improved outlook for the year.
TXMD earnings call for the period ending June 30, 2019.
The women's health company reported first-quarter 2019 operating results.
TXMD earnings call for the period ending March 31, 2019.
Are intrepid short-sellers taking advantage of misguided enthusiasm?